Alex Thompson CFA
Stock Analyst at Stifel Nicolaus
(4.98)
# 45
Out of 4,651 analysts
288
Total ratings
75%
Success rate
49.5%
Average return
Main Sectors:
Stocks Rated by Alex Thompson CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SEPN Septerna | Maintained: Buy | $49 → $46 | $44.50 | +3.37% | 3 | Aug 16, 2026 | |
| VRDN Viridian Therapeutics | Maintained: Buy | $40 | $22.08 | +81.16% | 19 | Aug 13, 2026 | |
| SYRE Spyre Therapeutics | Maintained: Buy | $123 | $103.63 | +18.69% | 20 | Aug 13, 2026 | |
| DNTH Dianthus Therapeutics | Maintained: Buy | $133 | $115.96 | +14.69% | 13 | Aug 13, 2026 | |
| KYMR Kymera Therapeutics | Maintained: Buy | $132 | $117.39 | +12.45% | 11 | Aug 13, 2026 | |
| CGEM Cullinan Therapeutics | Maintained: Buy | $28 | $20.34 | +37.66% | 7 | Aug 13, 2026 | |
| JBIO Jade Biosciences | Maintained: Buy | $40 | $24.71 | +61.88% | 3 | Aug 13, 2026 | |
| ALMS Alumis | Maintained: Buy | $44 | $25.31 | +73.84% | 6 | Aug 13, 2026 | |
| IMVT Immunovant | Maintained: Buy | $49 → $57 | $41.82 | +36.30% | 17 | Aug 11, 2026 | |
| EVMN Evommune | Maintained: Buy | $54 → $30 | $14.65 | +104.78% | 3 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $62 | $62.14 | -0.23% | 31 | Aug 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,255 → $1,282 | $851.29 | +50.59% | 30 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $68 | $41.95 | +62.10% | 7 | Jul 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $83 → $85 | $84.70 | +0.35% | 13 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $2.14 | +133.64% | 4 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $150 | $111.04 | +35.09% | 10 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $135 → $133 | $134.55 | -1.15% | 15 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $2.36 | +111.86% | 2 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 → $39 | $19.59 | +99.08% | 6 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $332 → $328 | $248.50 | +31.99% | 16 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 → $4 | $5.78 | -30.80% | 13 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $56 → $85 | $58.47 | +45.37% | 11 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $13 → $19 | $16.47 | +15.36% | 8 | Mar 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 → $3 | $1.07 | n/a | 17 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $13.92 | n/a | 2 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $42.58 | n/a | 1 | Aug 8, 2023 |
Septerna
Aug 16, 2026
Maintained: Buy
Price Target: $49 → $46
Current: $44.50
Upside: +3.37%
Viridian Therapeutics
Aug 13, 2026
Maintained: Buy
Price Target: $40
Current: $22.08
Upside: +81.16%
Spyre Therapeutics
Aug 13, 2026
Maintained: Buy
Price Target: $123
Current: $103.63
Upside: +18.69%
Dianthus Therapeutics
Aug 13, 2026
Maintained: Buy
Price Target: $133
Current: $115.96
Upside: +14.69%
Kymera Therapeutics
Aug 13, 2026
Maintained: Buy
Price Target: $132
Current: $117.39
Upside: +12.45%
Cullinan Therapeutics
Aug 13, 2026
Maintained: Buy
Price Target: $28
Current: $20.34
Upside: +37.66%
Jade Biosciences
Aug 13, 2026
Maintained: Buy
Price Target: $40
Current: $24.71
Upside: +61.88%
Alumis
Aug 13, 2026
Maintained: Buy
Price Target: $44
Current: $25.31
Upside: +73.84%
Immunovant
Aug 11, 2026
Maintained: Buy
Price Target: $49 → $57
Current: $41.82
Upside: +36.30%
Evommune
Aug 11, 2026
Maintained: Buy
Price Target: $54 → $30
Current: $14.65
Upside: +104.78%
Aug 9, 2026
Maintained: Hold
Price Target: $62
Current: $62.14
Upside: -0.23%
Jul 28, 2026
Maintained: Buy
Price Target: $1,255 → $1,282
Current: $851.29
Upside: +50.59%
Jul 22, 2026
Maintained: Buy
Price Target: $68
Current: $41.95
Upside: +62.10%
Jul 8, 2026
Downgraded: Hold
Price Target: $83 → $85
Current: $84.70
Upside: +0.35%
Jul 6, 2026
Maintained: Buy
Price Target: $5
Current: $2.14
Upside: +133.64%
Jun 29, 2026
Maintained: Buy
Price Target: $150
Current: $111.04
Upside: +35.09%
Jun 29, 2026
Maintained: Buy
Price Target: $135 → $133
Current: $134.55
Upside: -1.15%
May 28, 2026
Reiterated: Buy
Price Target: $5
Current: $2.36
Upside: +111.86%
May 15, 2026
Maintained: Buy
Price Target: $36 → $39
Current: $19.59
Upside: +99.08%
May 8, 2026
Maintained: Buy
Price Target: $332 → $328
Current: $248.50
Upside: +31.99%
May 8, 2026
Maintained: Hold
Price Target: $2 → $4
Current: $5.78
Upside: -30.80%
Mar 5, 2026
Maintained: Buy
Price Target: $56 → $85
Current: $58.47
Upside: +45.37%
Mar 1, 2026
Maintained: Hold
Price Target: $13 → $19
Current: $16.47
Upside: +15.36%
Mar 3, 2025
Downgraded: Hold
Price Target: $32 → $3
Current: $1.07
Upside: n/a
Nov 7, 2024
Reiterated: Buy
Price Target: $23
Current: $13.92
Upside: n/a
Aug 8, 2023
Initiated Coverage: Buy
Price Target: $34
Current: $42.58
Upside: n/a